Zilretta (Flexion Therapeutics, Inc.)
Welcome to the PulseAid listing for the Zilretta drug offered from Flexion Therapeutics, Inc.. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Flexion Therapeutics, Inc. |
NON-PROPRIETARY NAME: | triamcinolone acetonide extended-release injectable suspension |
SUBSTANCE NAME: | |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | |
ROUTE: | INTRA-ARTICULAR |
DOSAGE FORM: | KIT |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2017-10-06 |
END MARKETING DATE: | 0000-00-00 |
Zilretta HUMAN PRESCRIPTION DRUG Details:
Item Description | Zilretta from Flexion Therapeutics, Inc. |
LABELER NAME: | Flexion Therapeutics, Inc. |
DEA SCHEDULE: | |
ACTIVE STRENGTH: | () |
START MARKETING DATE: | 2017-10-06 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 70801-003_5b34354d-aa46-6bea-e053-2a91aa0addff |
PRODUCT NDC: | 70801-003 |
APPLICATION NUMBER: | NDA208845 |